Schering Cost Cuts Run Deep: Consumer Health Unit In Danger Of Divestiture?
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough will retain its Consumer Health Care business in the near-term but may choose to sell the unit as it undertakes a broad restructuring plan that includes an unprecedented dividend slash to cut costs
You may also be interested in...
Rx Firms Keeping A Close Eye On Lagging OTC Market Growth
Roche's decision to shop its OTC unit is an example of a pharmaceutical company putting increased profit margins ahead of long-term steady cash flow
Rx Firms Keeping A Close Eye On Lagging OTC Market Growth
Roche's decision to shop its OTC unit is an example of a pharmaceutical company putting increased profit margins ahead of long-term steady cash flow
Rx Firms Keeping A Close Eye On Lagging OTC Market Growth
Roche's decision to shop its OTC unit is an example of a pharmaceutical company putting increased profit margins ahead of long-term steady cash flow